drugset / Trial / NCT00511563

A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

NCT00511563

Phase 2 Withdrawn GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

To better understand the way that GW876008 and GSK561679 work on hormone responses in patients with Irritable Bowel Syndrome.

Timeline

Start
2007-08
Primary completion
2012-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule
Subject VERUCERFONT Small molecule